304 related articles for article (PubMed ID: 12360291)
1. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
Stenoien DL; Mielke M; Mancini MA
Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
[TBL] [Abstract][Full Text] [Related]
2. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
3. Inefficient degradation of truncated polyglutamine proteins by the proteasome.
Holmberg CI; Staniszewski KE; Mensah KN; Matouschek A; Morimoto RI
EMBO J; 2004 Oct; 23(21):4307-18. PubMed ID: 15470501
[TBL] [Abstract][Full Text] [Related]
4. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
Verhoef LG; Lindsten K; Masucci MG; Dantuma NP
Hum Mol Genet; 2002 Oct; 11(22):2689-700. PubMed ID: 12374759
[TBL] [Abstract][Full Text] [Related]
5. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
[TBL] [Abstract][Full Text] [Related]
6. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
Nozaki K; Onodera O; Takano H; Tsuji S
Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
[TBL] [Abstract][Full Text] [Related]
7. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.
Cummings CJ; Reinstein E; Sun Y; Antalffy B; Jiang Y; Ciechanover A; Orr HT; Beaudet AL; Zoghbi HY
Neuron; 1999 Dec; 24(4):879-92. PubMed ID: 10624951
[TBL] [Abstract][Full Text] [Related]
9. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT
Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing.
Sun J; Xu H; Negi S; Subramony SH; Hebert MD
J Neurosci Res; 2007 Aug; 85(11):2306-17. PubMed ID: 17526020
[TBL] [Abstract][Full Text] [Related]
11. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
Jana NR; Nukina N
J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
[TBL] [Abstract][Full Text] [Related]
13. Intranuclear inclusions and the ubiquitin-proteasome pathway: digestion of a red herring?
Floyd JA; Hamilton BA
Neuron; 1999 Dec; 24(4):765-6. PubMed ID: 10624938
[No Abstract] [Full Text] [Related]
14. Polyglutamine-mediated aggregation and cell death.
de Cristofaro T; Affaitati A; Feliciello A; Avvedimento EV; Varrone S
Biochem Biophys Res Commun; 2000 Jun; 272(3):816-21. PubMed ID: 10860836
[TBL] [Abstract][Full Text] [Related]
15. CREB-binding protein sequestration by expanded polyglutamine.
McCampbell A; Taylor JP; Taye AA; Robitschek J; Li M; Walcott J; Merry D; Chai Y; Paulson H; Sobue G; Fischbeck KH
Hum Mol Genet; 2000 Sep; 9(14):2197-202. PubMed ID: 10958659
[TBL] [Abstract][Full Text] [Related]
16. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.
Chai Y; Shao J; Miller VM; Williams A; Paulson HL
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9310-5. PubMed ID: 12084819
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.
Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EM; Orr HT; Botas J; Zoghbi HY
Cell; 2003 May; 113(4):457-68. PubMed ID: 12757707
[TBL] [Abstract][Full Text] [Related]
18. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.
Takahashi J; Tanaka J; Arai K; Funata N; Hattori T; Fukuda T; Fujigasaki H; Uchihara T
J Neuropathol Exp Neurol; 2001 Apr; 60(4):369-76. PubMed ID: 11305872
[TBL] [Abstract][Full Text] [Related]
20. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
Kaytor MD; Wilkinson KD; Warren ST
J Neurochem; 2004 May; 89(4):962-73. PubMed ID: 15140195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
